Annual report pursuant to Section 13 and 15(d)

10. Preferred Stock Equity Statement (Details - Equity schedule)

10. Preferred Stock Equity Statement (Details - Equity schedule) - USD ($)	2 Months Ended	10 Months Ended	12 Months Ended
	Dec. 31, 2015	Nov. 02, 2015	Dec. 31, 2016
Preferred Stock Series B
Beginning balance, shares	5,000	5,000	5,000
Beginning balance, value	$ 1	$ 1	$ 50
Conversion of Series B Preferred stock into common stock, shares converted			(5,000)
Conversion of Series B Preferred stock into common stock, value			$ (50)
Cancellation of Medytox shares, shares cancelled	(5,000)
Cancellation of Medytox shares, value	$ (1)
Issuance of Rennova shares, shares issued	5,000
Issuance of Rennova shares, value	$ 50
Ending balance, shares	5,000	5,000	0
Ending balance, value	$ 50	$ 1	$ 0
Preferred Stock Series C
Beginning balance, shares	0	0	9,000
Beginning balance, value	$ 0	$ 0	$ 90
Preferred stock converted to common stock, shares converted			(260)
Preferred stock converted to common stock, value converted			$ (3)
Exchange of Series C Preferred Stock and warrants for Series G Preferred Stock and warrants, shares			(8,740)
Exchange of Series C Preferred Stock and warrants for Series G Preferred Stock and warrants, value			$ (87)
Stock issued for cash, shares	9,000
Stock issued for cash, value	$ 90
Ending balance, shares	9,000	0	0
Ending balance, value	$ 90	$ 0	$ 0
Preferred Stock Series D
Beginning balance, shares	0	200,000	0
Beginning balance, value	$ 0	$ 20	$ 0
Preferred stock converted to common stock, shares converted		(200,000)
Preferred stock converted to common stock, value converted		$ (20)
Ending balance, shares	0	0	0
Ending balance, value	$ 0	$ 0	$ 0
Preferred Stock Series E
Beginning balance, shares	45,000	100,000	45,000
Beginning balance, value	$ 4	$ 10	$ 450
Preferred stock converted to common stock, shares converted		(55,000)
Preferred stock converted to common stock, value converted		$ (6)
Cancellation of Series E Preferred Stock, shares			(45,000)
Cancellation of Series E Preferred Stock, value			$ (450)
Cancellation of Medytox shares, shares cancelled	(45,000)
Cancellation of Medytox shares, value	$ (4)
Issuance of Rennova shares, shares issued	45,000
Issuance of Rennova shares, value	$ 450
Ending balance, shares	45,000	45,000	0
Ending balance, value	$ 450	$ 4	$ 0
Preferred Stock Series G
Beginning balance, shares	0	0	0
Beginning balance, value	$ 0	$ 0	$ 0
Exchange of Series C Preferred Stock and warrants for Series G Preferred Stock and warrants, shares			13,793
Exchange of Series C Preferred Stock and warrants for Series G Preferred Stock and warrants, value			$ 138
Conversion of Series G Preferred stock into common stock, shares converted			(5,232)
Conversion of Series G Preferred stock into common stock, value			$ (53)
Redemption of Series G Preferred Stock, shares redeemed			(8,346)
Redemption of Series G Preferred Stock, value			$ (83)
Ending balance, shares	0	0	215
Ending balance, value	$ 0	$ 0	$ 2
Preferred Stock Series H
Beginning balance, shares	0	0	0
Beginning balance, value	$ 0	$ 0	$ 0
Stock issued for cash, shares			12,350
Stock issued for cash, value			$ 124
Conversion of Series H Preferred stock into common stock, shares converted			(2,331)
Conversion of Series H Preferred stock into common stock, value			$ (24)
Ending balance, shares	0	0	10,019
Ending balance, value	$ 0	$ 0	$ 100
Preferred Stock Total
Beginning balance, shares	50,000	305,000	59,000
Beginning balance, value	$ 5	$ 31	$ 590
Preferred stock converted to common stock, shares converted		(255,000)	(260)
Preferred stock converted to common stock, value converted		$ (26)	$ (3)
Exchange of Series C Preferred Stock and warrants for Series G Preferred Stock and warrants, shares			5,053
Exchange of Series C Preferred Stock and warrants for Series G Preferred Stock and warrants, value			$ 51
Conversion of Series G Preferred stock into common stock, shares converted			(5,232)
Conversion of Series G Preferred stock into common stock, value			$ (53)
Conversion of Series B Preferred stock into common stock, shares converted			(5,000)
Conversion of Series B Preferred stock into common stock, value			$ (50)
Cancellation of Series E Preferred Stock, shares			(45,000)
Cancellation of Series E Preferred Stock, value			$ (450)
Cancellation of Medytox shares, shares cancelled	(50,000)
Cancellation of Medytox shares, value	$ (5)
Issuance of Rennova shares, shares issued	50,000
Issuance of Rennova shares, value	$ 500
Stock issued for cash, shares	9,000		12,350
Stock issued for cash, value	$ 90		$ 124
Redemption of Series G Preferred Stock, shares redeemed			(8,346)
Redemption of Series G Preferred Stock, value			$ (83)
Conversion of Series H Preferred stock into common stock, shares converted			(2,331)
Conversion of Series H Preferred stock into common stock, value			$ (24)
Ending balance, shares	59,000	50,000	10,234
Ending balance, value	$ 590	$ 5	$ 102